Cargando…
Hypoxia and Hypoxia-Inducible Factors in Lymphedema
Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017680/ https://www.ncbi.nlm.nih.gov/pubmed/35450048 http://dx.doi.org/10.3389/fphar.2022.851057 |
_version_ | 1784688826196688896 |
---|---|
author | Jiang, Xinguo Tian, Wen Kim, Dongeon McQuiston, Alexander S. Vinh, Ryan Rockson, Stanley G. Semenza, Gregg L. Nicolls, Mark R. |
author_facet | Jiang, Xinguo Tian, Wen Kim, Dongeon McQuiston, Alexander S. Vinh, Ryan Rockson, Stanley G. Semenza, Gregg L. Nicolls, Mark R. |
author_sort | Jiang, Xinguo |
collection | PubMed |
description | Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debilitating disease. Hypoxia is a recognized feature of inflammation, obesity, and fibrosis. Understanding hypoxia-regulated pathways in lymphedema may provide new insights into the pathobiology of this chronic disorder and help develop new medicinal treatments. |
format | Online Article Text |
id | pubmed-9017680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90176802022-04-20 Hypoxia and Hypoxia-Inducible Factors in Lymphedema Jiang, Xinguo Tian, Wen Kim, Dongeon McQuiston, Alexander S. Vinh, Ryan Rockson, Stanley G. Semenza, Gregg L. Nicolls, Mark R. Front Pharmacol Pharmacology Lymphedema is a chronic inflammatory disorder characterized by edema, fat deposition, and fibrotic tissue remodeling. Despite significant advances in lymphatic biology research, our knowledge of lymphedema pathology is incomplete. Currently, there is no approved pharmacological therapy for this debilitating disease. Hypoxia is a recognized feature of inflammation, obesity, and fibrosis. Understanding hypoxia-regulated pathways in lymphedema may provide new insights into the pathobiology of this chronic disorder and help develop new medicinal treatments. Frontiers Media S.A. 2022-03-28 /pmc/articles/PMC9017680/ /pubmed/35450048 http://dx.doi.org/10.3389/fphar.2022.851057 Text en Copyright © 2022 Jiang, Tian, Kim, McQuiston, Vinh, Rockson, Semenza and Nicolls. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jiang, Xinguo Tian, Wen Kim, Dongeon McQuiston, Alexander S. Vinh, Ryan Rockson, Stanley G. Semenza, Gregg L. Nicolls, Mark R. Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title | Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title_full | Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title_fullStr | Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title_full_unstemmed | Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title_short | Hypoxia and Hypoxia-Inducible Factors in Lymphedema |
title_sort | hypoxia and hypoxia-inducible factors in lymphedema |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017680/ https://www.ncbi.nlm.nih.gov/pubmed/35450048 http://dx.doi.org/10.3389/fphar.2022.851057 |
work_keys_str_mv | AT jiangxinguo hypoxiaandhypoxiainduciblefactorsinlymphedema AT tianwen hypoxiaandhypoxiainduciblefactorsinlymphedema AT kimdongeon hypoxiaandhypoxiainduciblefactorsinlymphedema AT mcquistonalexanders hypoxiaandhypoxiainduciblefactorsinlymphedema AT vinhryan hypoxiaandhypoxiainduciblefactorsinlymphedema AT rocksonstanleyg hypoxiaandhypoxiainduciblefactorsinlymphedema AT semenzagreggl hypoxiaandhypoxiainduciblefactorsinlymphedema AT nicollsmarkr hypoxiaandhypoxiainduciblefactorsinlymphedema |